Ask AI
ProCE Banner Activity

HER2 Assessment and Testing in 2025: What HCPs Need to Know

Slideset

Download these slides from an ASCO 2025 live satellite symposium on assessing for HER2-low or ultralow status in patients with metastatic breast cancer based on the latest clinical guidelines and expert recommended best practices.

Released: May 23, 2025

Expiration: November 22, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.